Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.

SNPHY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.04B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.16.91.97%13%-0.1
$15.03

Current Fair Value

19.6% upside

Undervalued by 19.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.04 Billion
Enterprise Value$-41,547,918,368.00
Annual dividend$0.23
Dividend yield1.97%
Earnings per Share$121.43
Beta0.24
Outstanding Shares321,344,079

Return

Return on Equity12.79%ROE
Return on Assets9.30%
Return on Invested Capital13.77%

Valuation & Multiples

P/E Ratio16.91P/E Ratio
PEG1819.88PEG
Price to Sales0.01Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue2.05
Enterprise Value to EBIT12.89
Enterprise Value to Net Income-2
Total Debt to Enterprise0.06
Debt to Equity0.12Debt to Equity

Revenue Sources

No data

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.00%0%
Total Invested$325▼ 19.35%
Investors Holding10%

About Santen Pharmaceutical Co., Ltd.

3,968 employees
CEO: Takeshi Ito

Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addr...